Alfuzosin: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Tom Morris
(+subpages)
mNo edit summary
 
(3 intermediate revisions by 3 users not shown)
Line 2: Line 2:


In [[medicine]], '''alfuzosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s.
In [[medicine]], '''alfuzosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s.
==History==
Uroxatral brand of alfuzosin was approved by the [[Food and Drug Administration]] in the [[United States of America]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2003.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=021287 Drugs@FDA]. U S Food and Drug Administration</ref> A generic version was approved with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=079013 Drugs@FDA]. U S Food and Drug Administration</ref>
<!--
==Pharmacology==
===Administration===
===Distribution===
===Metabolism===
===Excretion===
===Toxicity===
-->


==External links==
==External links==
{{CZMed}}
{{CZMed}}
==References==
<references/>[[Category:Suggestion Bot Tag]]

Latest revision as of 11:01, 8 July 2024

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, alfuzosin is a selective antagonist of alpha1-adrenergic receptors.

History

Uroxatral brand of alfuzosin was approved by the Food and Drug Administration in the United States of America with a New Drug Application (NDA) in 2003.[1] A generic version was approved with a Abbreviated New Drug Application (ANDA) in 2009.[2]


External links

The most up-to-date information about Alfuzosin and other drugs can be found at the following sites.


References

  1. Drugs@FDA. U S Food and Drug Administration
  2. Drugs@FDA. U S Food and Drug Administration